List your company
ResearchFormerly WizWand

Medical Image Segmentation on ACDC (100 patients total test)

92.9Dice ScorePCL
25.40442.92760.4577.973Jun 16, 2021Aug 6, 2021Sep 27, 2021Nov 18, 2021Jan 9, 2022Mar 2, 2022Apr 23, 2022
Updated 8mo ago

Evaluation results

MethodLinks
PCLM (Number of patients)=80, Validation=5-fold cross-validation2021.0692.9
RandomM (Number of patients)=80, Validation=5-fold cross-validation2021.0692.8
PIRLM (Number of patients)=80, Validation=5-fold cross-validation2021.0692.7
SimCLRM (Number of patients)=80, Validation=5-fold cross-validation2021.0692.7
GCLM (Number of patients)=80, Validation=5-fold cross-validation2021.0692.7
RotationM (Number of patients)=80, Validation=5-fold cross-validation2021.0692.5
PCLM (Number of patients)=30, Validation=5-fold cross-validation2021.0691.9
SimCLRM (Number of patients)=30, Validation=5-fold cross-validation2021.0691.3
GCLM (Number of patients)=30, Validation=5-fold cross-validation2021.0691.3
PIRLM (Number of patients)=30, Validation=5-fold cross-validation2021.0691.2
RotationM (Number of patients)=30, Validation=5-fold cross-validation2021.0691
RandomM (Number of patients)=30, Validation=5-fold cross-validation2021.0690.9
PCLM (Number of patients)=20, Validation=5-fold cross-validation2021.0690.9
PCLM (Number of patients)=15, Validation=5-fold cross-validation2021.0690.4
GCLM (Number of patients)=20, Validation=5-fold cross-validation2021.0690.2
RotationM (Number of patients)=20, Validation=5-fold cross-validation2021.0689.8
PIRLM (Number of patients)=20, Validation=5-fold cross-validation2021.0689.6
RandomM (Number of patients)=20, Validation=5-fold cross-validation2021.0689.4
SimCLRM (Number of patients)=20, Validation=5-fold cross-validation2021.0689.4
GCLM (Number of patients)=15, Validation=5-fold cross-validation2021.0689.1
RotationM (Number of patients)=15, Validation=5-fold cross-validation2021.0688.6
PCLM (Number of patients)=10, Validation=5-fold cross-validation2021.0688.5
PIRLM (Number of patients)=15, Validation=5-fold cross-validation2021.0688
RandomM (Number of patients)=15, Validation=5-fold cross-validation2021.0687.6
GCLM (Number of patients)=10, Validation=5-fold cross-validation2021.0687.2
SimCLRM (Number of patients)=15, Validation=5-fold cross-validation2021.0686.9
RotationM (Number of patients)=10, Validation=5-fold cross-validation2021.0686.8
PIRLM (Number of patients)=10, Validation=5-fold cross-validation2021.0686.5
PCLM (Number of patients)=6, Validation=5-fold cross-validation2021.0685
RandomM (Number of patients)=10, Validation=5-fold cross-validation2021.0684
SimCLRM (Number of patients)=10, Validation=5-fold cross-validation2021.0682.4
ProposedN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0482.4
PIRLM (Number of patients)=6, Validation=5-fold cross-validation2021.0682.3
RotationM (Number of patients)=6, Validation=5-fold cross-validation2021.0680.9
GCLM (Number of patients)=6, Validation=5-fold cross-validation2021.0680.3
FedRotationN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0478.3
RandomM (Number of patients)=6, Validation=5-fold cross-validation2021.0678.2
FedSwAVN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0478.2
Local CLN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0477
Random initN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0476.6
FedCAN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0476.6
FedSimCLRN=8, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0476.5
ProposedN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0474.5
SimCLRM (Number of patients)=6, Validation=5-fold cross-validation2021.0672.5
PCLM (Number of patients)=2, Validation=5-fold cross-validation2021.0667.1
FedRotationN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0466
FedSwAVN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0465.9
Local CLN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0463.7
GCLM (Number of patients)=2, Validation=5-fold cross-validation2021.0663.6
ProposedN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0463.1
FedSimCLRN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0461.9
Random initN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0461.8
FedCAN=4, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0461
RandomM (Number of patients)=2, Validation=5-fold cross-validation2021.0658.8
RotationM (Number of patients)=2, Validation=5-fold cross-validation2021.0657.2
FedRotationN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0450.8
ProposedN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0450.6
PIRLM (Number of patients)=2, Validation=5-fold cross-validation2021.0649.2
FedSwAVN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0448
Local CLN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0445.6
FedSimCLRN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0443.5
FedCAN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0441.7
Random initN=2, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0441.4
FedRotationN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0435.7
SimCLRM (Number of patients)=2, Validation=5-fold cross-validation2021.0635.2
FedSwAVN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0432.3
Local CLN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0432
FedSimCLRN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0428.8
Random initN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0428
FedCAN=1, Evaluation protocol=Local fine-tuning, Cross-validation=5-fold2022.0428